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Abstract
Vascular smooth muscle cells (VSMCs) in the normal aorta are described as having
a contractile phenotype because they can contract and do not proliferate. VSMCs
in pathological conditions such as atherosclerosis and restenosis can proliferate and
migrate,  but  lose  their  ability  to  contract,  which  is  referred  to  as  a  synthetic
phenotype. VSMCs show plasticity by changing their phenotype according to the
surrounding environment. When VSMCs are cultured on a plastic plate, which is
a  normal  two-dimensional  culture system, they display the synthetic  phenotype
because they proliferate and migrate without contraction. Recently, we successful‐
ly cultured VSMCs that display features similar to the contractile phenotype, using
type  I  collagen  three-dimensional  matrices,  “honeycombs,”  in  the  presence  of
abundant  fetal  bovine  serum  albumin.  VSMCs  cultured  in  honeycombs  stop
proliferating and can contract. The honeycomb culture system can maintain VSMCs
in the contractile phenotype for a long period of time. In this chapter, we show
the  method  of  this  new  culture  system  and  the  characteristics  of  VSMCs  in
honeycombs. It is expected that the use of this culture system will generate new
information on the characteristics of VSMCs.
Keywords: smooth muscle cell, three-dimensional culture, collagen, proliferation,
contraction
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1. Introduction
Vascular smooth muscle cells (VSMCs) are the major cell type in the vascular wall and their
main role is contraction. VSMCs in the normal aorta are classified as having a contractile
phenotype because they contract without proliferation. Conversely, VSMCs in vascular
diseases, such as restenosis after percutaneous coronary intervention and the formation of
atherosclerotic plaques, are described as having a synthetic phenotype because they can
proliferate and migrate, but lose their ability to contract. The phenotypic modulation of VSMCs
depends on the surrounding environment [1].
In order to conduct basic studies on the physiological function of VSMCs and to develop novel
medical treatments, cultured VSMCs are used. When VSMCs are cultured on a plastic plate in
the presence of 10% fetal bovine serum (FBS), which is the normal two-dimensional monolayer
culture system, the cells can migrate and proliferate, but lose their contractile ability [2].
Cultured VSMCs are classified as having a synthetic phenotype and are used as a model of
atherosclerotic lesion cells. As phenotypic modulation of VSMCs is responsible for restenosis
and the progression of atherosclerosis, they could be the main target of medicinal treatment,
and VSMCs cultured on plates are useful to evaluate the effects of medicines. However, there
is no acceptable cell model that reflects the nature of VSMCs in the normal aorta of a living
body. For this reason, information generated from synthetic VSMCs cannot be compared with
that from contractile VSMCs in the normal aorta. In this chapter, we describe a new culture
system for VSMCs that maintain their contractile phenotype.
2. Method of culture of VSMCs in type I collagen three-dimensional
“honeycomb” matrices
We reported a method for culturing contractile VSMCs by using three-dimensional matrices,
so-called “honeycombs.” Honeycombs are type I collagen sponges that can be obtained from
Koken Co., Ltd. (Japan). Honeycombs are prepared from 0.5% type I atelocollagen in an acid
solution by neutralization with ammonia gas to separate the collagen fibrils and lyophilization
[3]. The structure of the honeycomb is porous and consists of many tubes aligned side by side,
similar to a beehive [4, 5]. The pore diameter of the honeycomb is controlled by altering the
concentration of the collagen solution and ammonia gas. When a higher concentration of
ammonia gas is used, smaller pores are produced, and vice versa [3]. The diameter of each
pore of the tubes is 100–500 μm, and we usually use a pore size of 200–300 μm for rabbit and
human VSMCs. The honeycombs are cut vertically into cubes of dimensions 5 × 5 × 2 or 3 × 3
× 2 mm for culturing VSMCs.
The initial culture of VSMCs in a honeycomb is as follows (Figure 1): rabbit or mouse VSMCs
cultured on plates (synthetic phenotype) in Dulbecco’s modified Eagle’s medium (DMEM)
containing 10% FBS are used. The honeycombs are pre-incubated with DMEM containing 10%
FBS and the air in each pore of the honeycomb is removed by centrifugation. VSMCs cultured
on plates are incubated with trypsin-EDTA, and the released cells are collected by centrifuga‐
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tion. The collected cells are suspended in 300–400 μL DMEM containing 10% FBS and are
incubated with the honeycombs (approximately 2.0 – 3.0 × 106 cells per 30 honeycombs) on a
dish (diameter, 6 cm) for 3 h at 37°C. Then, 3–5 mL culture medium is added. The medium is
changed every 2–3 days. For human VSMCs, a commercial medium supplemented with
epidermal growth factor, fibroblast growth factor-B, insulin, and 2% FBS is used.
Figure 1. Preparation of VSMCs into honeycombs. Rabbit, mouse, and human VSMCs can be cultured successfully in
honeycombs with this chart. The required number of cells are cultured on a plate as synthetic VSMCs and transferred
to the honeycombs. To collect VSMCs in honeycombs for analysis, the honeycombs are treated with collagenase-I.
By visualizing the binding process of VSMCs to honeycombs using a real-time cultured cell
monitoring system [6], VSMCs are fixed at one attachment point and move little by little using
other attachment points, resembling the movement of an inchworm. After 25 h incubation, the
positions of the VSMCs are fixed, and they form cross-bridges in the honeycombs. VSMCs in
honeycombs form 2–5 attachment points per cell (Figure 2). However, mouse VSMCs (length
of long axis, 33–139 [80 ± 29] μm) do not make cross-bridges in honeycombs in which the
diameter of the pore is about 500 μm. These results suggest that the relationship between pore
size and the length of the long axis of VSMCs is important for the formation of cellular cross-
bridges. The inner wall of honeycombs with a larger pore size may function as a “flat floor”
for VSMCs, as if it were a plastic plate.
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 Figure 2. Cross-bridges of VSMCs on honeycombs. These pictures are electron microscopic observations of rabbit and
mouse VSMCs cultured in honeycombs. (A) Rabbit VSMCs cultured in honeycombs of pore size ≤200 μm; (B) rabbit
VSMCs cultured in honeycombs of pore size 300–500 μm; (C) mouse VSMCs cultured in honeycombs of pore size ≤200
μm; and (D) mouse VSMCs cultured in honeycombs of pore size 300–500 μm. Arrows show VSMCs. Scale bars, 50 μm.
Data adapted from reference 6.
3. Proliferative inhibition of VSMCs cultured in honeycombs
Various kinds of cells, such as human fibroblasts, CHO-K1, BHK-21, and bovine endothelial
cells [3], can be cultured successfully in honeycombs. These cells grow normally in honey‐
combs. However, the proliferation of VSMCs can be controlled easily by the pore size of the
honeycombs.
When synthetic rabbit VSMCs are used for culture in honeycombs (pore size, about 200 μm),
they stop proliferating immediately when they form cross-bridges [4]. [3H]Thymidine is
incorporated at a low level into VSMCs cultured in honeycombs, and cell number does not
change during culture. VSMCs can be cultured in honeycombs for approximately 3 months
with medium change. However, when rabbit VSMCs are cultured in honeycombs with larger
pore size (100–500 μm) (Figure 3), they proliferate for the first few days, but then stop
proliferating and cell number does not change [6]. The reason why cell number increases only
at the beginning of culture is as follows: in honeycombs with a smaller pore (≤200 μm), VSMCs
form cross-bridges independently of each other, but a large number of connected cells form
cross-bridges together at the wall of honeycombs with larger pores (100–500 μm) after the
initial increase in cell number at the beginning of culture. These data suggest that the formation
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of cross-bridges by VSMCs in honeycombs may be a significant step for the cessation of
proliferation.
 
Figure 3. Cross-bridges of rabbit VSMCs cultured in honeycombs for 14 days. Electron microscopic observation of rab‐
bit VSMCs cultured in honeycombs for 14 days. Rabbit VSMCs were cultured in honeycombs of pore size 100–500 μm.
The pores enclosed by squares contain a large number of VSMCs, and the pores enclosed by circles contain a small
number of VSMCs forming cross-bridges. Arrows show VSMCs. Scale bar, 100 μm. Data adapted from reference 6.
When VSMCs are cultured on collagen-coated plates, their proliferation rate increases.
Conversely, when VSMCs are cultured on collagen gels, their proliferation stops via the cdk2
inhibitor p27kip1 [7]. However, proliferative inhibition persists for less than 1 week because
VSMCs dissolve the collagen gel and start to proliferate again (unpublished data). Therefore,
it is expected that both the higher-order structure of collagen and pore size of the honeycombs
are considerable factors for the proliferative inhibition of VSMCs.
Although VSMCs in honeycombs stop proliferating immediately, p27kip1 expression increases
after incubation for 2–3 days (unpublished data). From this observation, it is expected that
p27kip1 may work to keep VSMCs at a resting state and not as the initiator of proliferative
inhibition. Taken together with electron microscopic observations and data for growth in
honeycombs, proliferative inhibition occurs in parallel with a decrease in the number of focal
adhesions, including reduced levels of focal adhesion kinase (FAK). As a high level of
phosphorylated FAK promotes proliferative activity [8], the low level of phosphorylated FAK
is one of the reasons for proliferative inhibition of VSMCs in honeycombs.
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An additional mechanism for the proliferative inhibition of VSMCs in this three-dimensional
culture system is the expression of ornithine decarboxylase antizyme 1 (OAZ1), which is a key
regulator of intracellular polyamines. Polyamines (putrescine, spermidine, and spermine),
which are multivalent organic cations, are essential for cell growth [9]. The proliferation and
transformation of cells induced by oncogenes, carcinogens, and viruses are characterized by
increases in the levels of intracellular polyamines due to their increased biosynthesis and
uptake [10]. Ornithine decarboxylase (ODC) is the rate-limiting enzyme of polyamine biosyn‐
thesis. OAZ1 inhibits the activity of ODC and increases its degradation by forming an OAZ1-
ODC complex [11, 12]. OAZ1 also decreases the uptake of polyamines independent of its effects
on ODC [13, 14].
When VSMCs proliferate on plates, the intracellular content of polyamines increases. Con‐
versely, polyamine content is maintained at a low level in VSMCs cultured in honeycombs [15].
VSMCs stably transfected with the ODC gene (ODC-VSMCs) and cultured on plates increase
their rate of proliferation, which is accompanied by an increase of polyamine content (espe‐
cially spermidine) and phosphorylated FAK and a decrease in marker proteins of differentia‐
tion, α-actin, and myosin heavy chain in comparison to VSMCs cultured on plates (Figure 4).
As ODC is an oncogene and induces an excess of polyamines [16], it is assumed that ODC may
promote the proliferative activity of VSMCs cultured in honeycombs. However, the prolifer‐
ation of ODC-VSMCs also ceases in honeycombs, similar to normal VSMCs with low levels of
spermidine and phosphorylated FAK (Figure 4). Finally, culture of ODC-VSMCs in honey‐
combs increases the expression of α-actin and myosin heavy chain.
As shown in Figure 4, OAZ1 levels are higher in both VSMCs and ODC-VSMCs cultured in
honeycombs than in both VSMCs and ODC-VSMCs cultured on plates. OAZ1 is degraded in
ODC-VSMCs cultured on plates for up to 3 h after treatment with cycloheximide, but OAZ1
degradation in ODC-VSMCs cultured in honeycombs is limited over a 12 h incubation period
(Figure 4). This difference in OAZ1 stability may be the major reason for the high levels of
OAZ1 observed in VSMCs cultured in honeycombs. These results suggest that OAZ1 in
VSMCs cultured in honeycombs might enhance the degradation of ODC and inhibit polyamine
uptake. In fact, our data show that polyamine uptake is significantly lower in ODC-VSMCs
cultured in honeycombs than in ODC-VSMCs cultured on plates [15]. This could be one of the
reasons for the lower polyamine levels in VSMCs cultured in honeycombs than in VSMCs
cultured on plates.
When OAZ1 is transiently overexpressed in ODC-VSMCs (Figure 5), OAZ1 decreases the
number of ODC-VSMCs cultured on plates at day 3, whereas OAZ1 overexpression does not
change the number of ODC-VSMCs cultured in honeycombs. OAZ1 overexpression slightly
decreases the expression of ODC and phosphorylated FAK levels in ODC-VSMCs cultured on
plates. Surprisingly, OAZ1 overexpression influences the levels of myosin heavy chain in
ODC-VSMCs cultured on plates and in honeycombs, and influences the levels of α-actin in
ODC-VSMCs cultured in honeycombs. These results suggest that OAZ1 in VSMCs might
regulate intracellular polyamine levels and cellular proliferation. Moreover, OAZ1 levels may
influence the expression of α-actin and myosin heavy chain, which are the main components
of the contractile apparatus.
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Figure 4. OAZ1 in normal VSMCs and ODC-VSMCs, and the levels of various proteins expressed in VSMCs cultured
on plates and in honeycombs. (A) (a) VSMCs were transfected with three kinds of pTracer-CMV containing OAZ1
without T205, which do not need a frameshift for their expression of each type of OAZ1. Lane 1, pTracer-
OAZ∆T205∆AUG1, which expresses 24.5-kDa OAZ1; lane 2, pTracer-OAZ∆T205, which expresses 24.5- and 29-kDa
Three-Dimensional “Honeycomb” Culture System that Helps to Maintain the Contractile Phenotype of…
http://dx.doi.org/10.5772/60960
447
OAZ1; lane 3, pTracer-OAZ∆T205∆AUG2, which expresses 29-kDa OAZ1. After transfection, VSMCs were collected at
24 h, a cell extract was prepared, and Western blot analysis was performed. (b) Degree of inhibition of ODC by OAZ1
was measured. The activity of OAZ1 was determined as an inhibitory percentage of ODC activity of the extract from
ODC-overproducing FM3A (EXOD-1) cells. ●, extract from VSMCs expressing 24.5-kDa OAZ1; ▲, extract from
VSMCs expressing 29- and 24.5-kDa OAZ1; and ○, extract from VSMCs expressing 29-kDa OAZ1. Values are means of
duplicate determinations. (B) Inhibition of ODC activity using extracts from VSMCs cultured on plates and in honey‐
combs. OAZ1 activity was determined as an inhibitory percentage of ODC activity of the extract from EXOD-1 cells.
Values are means ± standard deviation (SD) of triplicate determinations. (C) Western blot analysis of OAZ1, ODC, ty‐
rosine-phosphorylated FAK (pY-FAK), α-actin, myosin heavy chain, and β-actin of VSMCs and ODC-VSMCs cultured
on plates and in honeycombs. P, EXOD-1 cells as a positive control. Relative intensity on day 7 was quantified. The
intensity of OAZ1 was quantified as the sum of the 29- and 24.5-kDa bands. ND, not detectable. Values are means ± SD
of triplicate determinations. (D) OAZ1 degradation. ODC-VSMCs cultured on plates and in honeycombs for 3 days
were treated with 20 μg/mL cycloheximide for the indicated time. Data adapted from reference 15.
VSMC proliferation is reportedly up-regulated via an increase in the stability of S-phase kinase-
associated protein-2, E3 ubiquitin protein ligase (SKP2) by autophosphorylation of FAK-
Tyr397 [17]. In ODC-VSMCs cultured on plates, the increased rate of proliferation is
accompanied by an increase of phosphorylated FAK. Interestingly, when the effect of spermine
on FAK autophosphorylation in vitro was investigated, FAK phosphorylation was stimulated
by spermine [15]. The low levels of intracellular polyamines in VSMCs cultured in honeycombs
could inhibit the autophosphorylation of FAK, and this may contribute to the proliferative
inhibition of VSMCs.
4. Differentiation of VSMCs cultured in honeycombs
Caldesmon is an actin-linked regulatory protein, and caldesmon heavy chain (h-CaD) is
expressed abundantly and specifically in contractile VSMCs. h-CaD localizes to the actomyosin
contractile structure in VSMCs as an integral component of smooth muscle thin filaments [18].
Caldesmon also works as a potent repressor of cancer cell invasion because its ectopic
expression reduces the number of podosomes/invadopodia and decreases extracellular matrix
degradation. The depletion of caldesmon facilitates the formation of podosomes/invadopodia
and cell invasion [19]. As VSMCs cultured in honeycombs for 14 days express h-CaD [4, 6],
these cells could be classified to the contractile phenotype.
Some other cells also differentiate in honeycombs. By usage of honeycomb scaffolds, rat axonal
regeneration [20], differentiation of pluripotent embryonic stem (ES) cell-derived embryoid
bodies (EBs) into hepatocyte-like cells [21], and differentiation of mesenchymal stem cells into
osteoblasts [22] have been reported. For example, EBs formed from ES cells become liver-
specific gene-positive and albumin-positive cells, and they form cord-like structures in
honeycombs that are not present in two-dimensional monolayer culture systems [21]. When
a honeycomb scaffold including EB-derived hepatocyte-like cells is transplanted into the
median lobes of partially hepatectomized nude mice, cells that are positive for both albumin
and cytokeratin 18 appear in the transplant and form clustered aggregates after 7 and 14 days.
These data suggest that a honeycomb is a useful scaffold culture system for regulation of
cellular differentiation and for advanced tissue engineering.
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Figure 5. Effect of the transient expression of OAZ1 in ODC-VSMCs cultured on plates and in honeycombs. After
ODC-VSMCs were transfected with pTracer-OAZΔT205ΔAUG1 (24.5-kDa OAZ1), the cells were cultured as shown in
(A). Transfected ODC-VSMCs were then cultured either on plates or in honeycombs for 1, 3, and 7 days. (B) Cell num‐
ber on days 1 and 3. (C) Western blot analysis of OAZ1, ODC, pY-FAK, α-actin, myosin heavy chain, and β-actin. Rela‐
tive intensity of proteins on day 7 was quantified. Values are means ± SD of triplicate determinations. Data adapted
from reference 15.
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5. Contraction of VSMCs cultured in honeycombs
VSMCs cultured on plates express the main components of the contractile apparatus and
cytoskeleton (including β-non-muscle actin filaments), but VSMCs cultured on plates do not
contract under normal culture conditions [23]. The size of honeycombs containing VSMCs is
significantly reduced over time [5], which could be due to the contraction of the VSMCs. A
key protein for the contraction of VSMCs cultured in honeycombs is filamin. Filamin A has a
molecular weight of 280 kDa and a molecular length of approximately 160 nm [24]. Filamin
dimers link actin filaments into orthogonal networks or parallel bundles, and an in vitro study
showed that the manner in which actin filaments are organized depends on the ratio of filamin
to actin [25]. Filamin mainly co-localizes with the β-non-muscle actin filaments in gizzard
SMCs [26, 27]. When ODC-VSMCs are used, the function of filamin in VSMCs becomes clear.
Filamin expression is dramatically decreased in ODC-VSMCs compared to VSMCs (Figure 6).
β-Non-muscle actin filaments in ODC-VSMCs cultured on plates are thinner than those of
VSMCs, although β-actin expression, as determined by Western blot analysis, is almost the
same in ODC-VSMCs as in VSMCs (Figure 6). These results suggest that the 280-kDa form of
filamin is responsible for the bundling of β-non-muscle actin filaments in VSMCs.
It is well known that filamin is degraded by μ- and m-calpain [28, 29]. When VSMCs are
cultured in honeycombs, 280-kDa filamin is degraded to 180-kDa filamin by calpains [5]. It is
expected that degraded filamin cannot induce the bundling of actin filaments, resulting in the
relative structural weakness of β-non-muscle actin filaments in VSMCs cultured in honey‐
combs. Observation of the intracellular distribution of filamin and β-actin by immunofluor‐
escence microscopy shows that filamin is situated along fibers and co-localizes with β-actin in
subconfluent VSMCs cultured on plates (Figure 7A and B). In honeycombs, filamin staining is
detected evenly in the cytoplasm and is not stained as fibers in most cells (Figure 7C and D).
It can be assumed that degraded filamin, which does not bind to β-non-muscle actin filaments,
is present in the cytoplasm of VSMCs cultured in honeycombs.
The expression levels of proteins involved in both the contractile apparatus (α-actin, myosin
heavy chain, and tropomyosin) and cytoskeleton (β-actin and α-actinin) in VSMCs cultured
in honeycombs are almost identical to those in VSMCs cultured on plates [5]. However, VSMCs
on plates express the 280-kDa form of filamin, whereas VSMCs cultured in honeycombs
express both the 280- and 180-kDa forms of filamin. α-Actin and β-actin co-localize in sub‐
confluent VSMCs cultured on plates and in VSMCs cultured in honeycombs, suggesting that
the contractile apparatus is aligned with β-non-muscle actin filaments [5].
These data from VSMCs cultured in honeycombs could explain why contraction, which is a
result of shortening of the contractile apparatus, is not observed in VSMCs cultured on plates.
VSMCs attach to rigid plastic plates via focal adhesions, and the resulting cytoskeletal tension,
which is maintained by β-non-muscle actin filaments, inhibits shortening of the contractile
apparatus. In honeycombs, VSMCs can contract because filamin degradation reduces cytos‐
keletal tension and allows shortening of the contractile apparatus [5].
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Figure 6. Expression and localization of filamin and β-actin in ODC-VSMCs. (A) Western blot analysis of filamin and
β-actin in VSMCs and ODC-VSMCs. VSMCs and ODC-VSMCs were cultured on plates to subconfluence. Lane 1,
VSMCs; lane 2, molecular marker; and lane 3, ODC-VSMCs. Localization of filamin and β-actin in VSMCs (B, C) and
ODC-VSMCs (D, E). VSMCs and ODC-VSMCs were cultured on plates to subconfluence. Green indicates filamin, and
red indicates β-actin. Scale bars, 20 μm (B, D); 5 μm (C, E). Data adapted from reference 5.
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Figure 7. Localization of filamin and β-actin in VSMCs. (A, B) VSMCs were cultured to subconfluence on a plate. (C,
D) VSMCs were cultured in honeycombs for 3 days. Green indicates filamin, and red indicates β-actin. Scale bars, 20
μm (A, C); 5 μm (B, D). Data adapted from reference 5.
When myocardial cells derived from newborn rats are cultured in honeycombs, the cells attach
to the honeycombs and start beating from the first day. The rate of beating increases gradually,
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and reaches the highest frequency of 162 beats per minute at day 8 [30]. However, the number
of myocardial cells increases significantly. From these data, it is shown that the honeycomb
scaffold may induce the functional aspects of cells even though it is unclear whether or not
cells cultured in honeycombs proliferate.
6. Reversibility of VSMCs between the contractile and synthetic
phenotypes
When VSMCs cultured in honeycombs are treated with collagenase-I and the released cells
are seeded in plastic plates, they start to proliferate again [5]. This result shows the remarkable
plasticity of VSMCs. The relationship between the culture system and phenotypic modulation
is shown in Figure 8.
Filamin A mRNA expression is almost identical in VSMCs cultured in honeycombs and on
plates, and VSMCs moved to plates mainly express the 280-kDa form of filamin after 12 h [5].
These observations indicate that filamin might contribute to the phenotypic modulation seen
in VSMCs.
Figure 8. Summary of VSMC phenotypic modulation in culture. These images are scanning electron microscopic obser‐
vations. Arrowheads show VSMCs and arrows show honeycombs. VSMCs cultured on plates express the synthetic
phenotype. This type of VSMC is de-differentiated and can proliferate. VSMCs cultured in honeycombs display similar
features to the contractile phenotype. These two phenotypes are reversible depending on the type of culture used.
These photographs were taken from reference 4 to make it easy to understand the culture system.
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7. Vision and agenda
The honeycomb culture system has been used for tissue engineering. For example, when
honeycombs filled with grown human adipose-derived stem cells were transplanted into nude
mice, bone formation was observed in vivo [31]. Another report showed that new bone
induction by KUSA/A1cells was promoted by using honeycomb culture [32]. Furthermore,
when human embryonic stem cells (hESCs) were co-cultured with Swiss 3T3 cells in honey‐
combs, type I collagen synthesis by Swiss 3T3 cells contributed to the hepatic maturation of
hESCs [33]. From these data, it can be seen that the honeycomb culture system has the potential
to help the regeneration of organs and to facilitate the analysis of intercellular interactions. In
the near future, in order to clarify the mechanism of the phenotypic modulation of VSMCs
involved in atherosclerosis, we intend to co-culture VSMCs and macrophages. In addition, the
reason for the proliferative inhibition of VSMCs cultured in honeycombs is still unclear. This
is our agenda that remains to be solved.
8. Conclusion
A summary of VSMC phenotypic modulation in culture is shown in Figure 8. The contractile
phenotype of VSMCs can be cultured stably using type I collagen three-dimensional matrices,
i.e., honeycombs, in the presence of 10% FBS. VSMCs in honeycombs stop proliferating and
can contract. The expression of OAZ1 and reduction of phosphorylated FAK levels contribute
partially to the proliferative inhibition of VSMCs in honeycombs. Filamin degradation reduces
cytoskeletal tension and allows shortening of the contractile apparatus. However, the detailed
mechanism by which VSMCs display features similar to those of aortic VSMCs when cultured
in honeycombs is still unclear. In order to clarify the regulation of phenotypic modulation,
further studies are needed.
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